Press Releases
August 27, 2014: Ryogen Awarded Two U.S. Patents Directed to Hepatitis C and Diabetes
July 29, 2014: Ryogen Awarded Two Patents Directed to Polynucleotide Sequences that Play Key Roles in Various Cancers
June 22, 2014: Ryogen Is Awarded Patent for Polynucleotides Related to Tumor-Suppressing Subtransferable Candidate 4
February 12, 2013: Ryogen Receives Nine Human Gene Patents in 2012
October 19, 2010: Ryogen Is Awarded Two Additional Patents for Human Genes
November 11, 2009: Ryogen Is Awarded New Patent
February 24, 2009: Ryogen is Awarded Patents on Two Human Genes
October 29, 2007: Ryogen Gets Patent on Soluble Aminopeptidase P Gene
January 10, 2007: Ryogen Licenses Human Aminopeptidase P Gene Patent to Invitrogen
August 15, 2006: Ryogen Licenses Human Aminopeptidase P Gene Patent to OriGene Technologies
July 6, 2006: Ryogen Licenses Human Aminopeptidase P Gene Patent to R&D Systems
April 5, 2005: Dr. James W. Ryan and IP Holdings Form Ryogen LLC to Commercialize Key Genomic Patents